Fifth Third Bancorp
IBB icon

Fifth Third Bancorp’s iShares Biotechnology ETF IBB Stock Holding History

Fifth Third Bancorp’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.62M Buy
27,352
+14,097
+106% +$2.41M 0.01% 767
2025
Q4 		$2.24M Buy
13,255
+40
+0.3% +$6.5K 0.01% 442
2025
Q3 		$1.91M Sell
13,215
-62
-0.5% -$8.46K 0.01% 483
2025
Q2 		$1.68M Sell
13,277
-74
-0.6% -$9.08K 0.01% 494
2025
Q1 		$1.71M Sell
13,351
-43
-0.3% -$5.83K 0.01% 473
2024
Q4 		$1.77M Sell
13,394
-333
-2% -$46.8K 0.01% 464
2024
Q3 		$2M Hold
13,727
– – 0.01% 470
2024
Q2 		$1.88M Sell
13,727
-30
-0.2% -$4K 0.01% 465
2024
Q1 		$1.89M Sell
13,757
-154
-1% -$21K 0.01% 474
2023
Q4 		$1.89M Sell
13,911
-45
-0.3% -$5.49K 0.01% 462
2023
Q3 		$1.71M Buy
13,956
+45
+0.3% +$5.72K 0.01% 469
2023
Q2 		$1.77M Sell
13,911
-201
-1% -$26.1K 0.01% 472
2023
Q1 		$1.82M Sell
14,112
-30
-0.2% -$3.93K 0.01% 460
2022
Q4 		$1.86M Sell
14,142
-182
-1% -$23.5K 0.01% 456
2022
Q3 		$1.68M Sell
14,324
-4,140
-22% -$514K 0.01% 452
2022
Q2 		$2.17M Sell
18,464
-3,888
-17% -$462K 0.01% 416
2022
Q1 		$2.91M Sell
22,352
-20,681
-48% -$2.69M 0.01% 403
2021
Q4 		$6.57M Buy
43,033
+1,009
+2% +$156K 0.03% 318
2021
Q3 		$6.79M Buy
42,024
+85
+0.2% +$14.3K 0.03% 305
2021
Q2 		$6.86M Sell
41,939
-1,714
-4% -$264K 0.03% 303
2021
Q1 		$6.57M Buy
43,653
+1,142
+3% +$181K 0.03% 303
2020
Q4 		$6.44M Buy
42,511
+7,690
+22% +$1.1M 0.03% 294
2020
Q3 		$4.71M Buy
34,821
+14,889
+75% +$2.02M 0.03% 326
2020
Q2 		$2.73M Buy
19,932
+2,475
+14% +$316K 0.02% 369
2020
Q1 		$1.88M Sell
17,457
-1,059
-6% -$122K 0.01% 386
2019
Q4 		$2.23M Sell
18,516
-2,394
-11% -$267K 0.01% 406
2019
Q3 		$2.08M Buy
20,910
+6,145
+42% +$643K 0.01% 398
2019
Q2 		$1.61M Buy
14,765
+1,424
+11% +$151K 0.01% 431
2019
Q1 		$1.49M Buy
13,341
+60
+0.5% +$6.58K 0.01% 421
2018
Q4 		$1.28M Buy
13,281
+141
+1% +$15K 0.01% 433
2018
Q3 		$1.6M Buy
13,140
+90
+0.7% +$10.6K 0.01% 427
2018
Q2 		$1.43M Sell
13,050
-81
-0.6% -$8.66K 0.01% 438
2018
Q1 		$1.4M Buy
13,131
+165
+1% +$18.3K 0.01% 445
2017
Q4 		$1.38M Sell
12,966
-66
-0.5% -$7.05K 0.01% 455
2017
Q3 		$1.45M Buy
13,032
+84
+0.6% +$8.98K 0.01% 454
2017
Q2 		$1.34M Sell
12,948
-51
-0.4% -$5.02K 0.01% 469
2017
Q1 		$1.27M Sell
12,999
-1,341
-9% -$128K 0.01% 486
2016
Q4 		$1.27M Buy
14,340
+480
+3% +$43.7K 0.01% 490
2016
Q3 		$1.34M Buy
13,860
+1,629
+13% +$155K 0.01% 483
2016
Q2 		$1.05M Buy
12,231
+51
+0.4% +$4.58K 0.01% 519
2016
Q1 		$1.06M Sell
12,180
-510
-4% -$45.6K 0.01% 528
2015
Q4 		$1.43M Sell
12,690
-1,332
-9% -$145K 0.01% 478
2015
Q3 		$1.42M Buy
14,022
+3,645
+35% +$437K 0.01% 483
2015
Q2 		$1.28M Buy
10,377
+819
+9% +$98K 0.01% 534
2015
Q1 		$1.09M Buy
9,558
+150
+2% +$16.5K 0.01% 574
2014
Q4 		$951K Sell
9,408
-156
-2% -$15.2K 0.01% 591
2014
Q3 		$872K Sell
9,564
-324
-3% -$28.4K 0.01% 589
2014
Q2 		$847K Buy
9,888
+513
+5% +$40.4K 0.01% 608
2014
Q1 		$739K Sell
9,375
-555
-6% -$46.2K 0.01% 636
2013
Q4 		$752K Sell
9,930
-2,757
-22% -$196K 0.01% 660
2013
Q3 		$886K Sell
12,687
-1,869
-13% -$122K 0.01% 604
2013
Q2 		$844K Buy
+14,556
New +$841K 0.01% 623

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fifth Third Bancorp's IBB Position: Q1 2026 in Review

Fifth Third Bancorp increased its iShares Biotechnology ETF (IBB) stake by 106% in Q1 2026, buying an estimated $2.41M and bringing the position to 27,352 shares worth $4.62M. The position accounts for 0.01% of the portfolio, ranked #767.

Fifth Third Bancorp first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.86M in Q2 2021. 918 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Fifth Third Bancorp held 27,352 shares of iShares Biotechnology ETF worth $4.62M as of Q1 2026.
  • Fifth Third Bancorp bought 14,097 iShares Biotechnology ETF shares in Q1 2026, an estimated $2.41M.
  • iShares Biotechnology ETF made up 0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #767 holding.
  • Fifth Third Bancorp first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Fifth Third Bancorp's iShares Biotechnology ETF position peaked at $6.86M in Q2 2021.
  • 918 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.